Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study.

Sanguineti G, Giannarelli D, Petrongari MG, Arcangeli S, Sangiovanni A, Saracino B, Farneti A, Faiella A, Conte M, Arcangeli G.

Radiat Oncol. 2019 Jan 30;14(1):23. doi: 10.1186/s13014-019-1223-2.

2.

Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.

Marucci L, Farneti A, Di Ridolfi P, Pinnaro P, Pellini R, Giannarelli D, Vici P, Conte M, Landoni V, Sanguineti G.

Head Neck. 2017 Sep;39(9):1761-1769. doi: 10.1002/hed.24832. Epub 2017 May 31.

PMID:
28560780
3.

Validation of DWI in assessment of radiotreated bone metastases in elderly patients.

Reginelli A, Silvestro G, Fontanella G, Sangiovanni A, Conte M, Nuzzo I, Calvanese M, Traettino M, Ferraioli P, Grassi R, Manzo R, Cappabianca S.

Int J Surg. 2016 Sep;33 Suppl 1:S148-53. doi: 10.1016/j.ijsu.2016.06.018. Epub 2016 Jul 5.

4.

Performance status versus anatomical recovery in metastatic disease: The role of palliative radiation treatment.

Reginelli A, Silvestro G, Fontanella G, Sangiovanni A, Conte M, Nuzzo I, Di Lecce A, Martino A, Grassi R, Murino P, Cappabianca S.

Int J Surg. 2016 Sep;33 Suppl 1:S126-31. doi: 10.1016/j.ijsu.2016.06.019. Epub 2016 Jun 21.

Supplemental Content

Loading ...
Support Center